March 13 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* Aurinia announces public offering of common shares
* Aurinia Pharmaceuticals-to use net proceeds of offering for research, development activities, phase 3 clinical trial activities for lupus nephritis Source text for Eikon: ID:nBw12KZmKa Further company coverage: AUP.TO